Testing tumor samples to guide treatment for advanced bile duct cancer
Treatments studied
Part of Cancer clinical trials.
This trial tests whether growing your tumor cells in the lab to see which drugs kill them can help choose a more effective treatment for your advanced bile duct cancer. If you join, your treatment may be personalized based on how your tumor responds to different drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have bile duct cancer that cannot be removed with surgery and has not been cured by other local treatments.
- You are expected to live at least 3 more months.
- You are generally well enough to carry out daily activities (ECOG score 0 or 1).
- Your liver, kidney, and bone marrow function are within acceptable ranges.
- You have not had radiation therapy in the past 12 weeks.
- You are willing to use effective birth control if there is any chance of pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called BTC-Ag-T, which uses your own immune cells enhanced in the lab to fight advanced biliary tract cancer (cancer of the bile ducts or gallbladder). It's designed for patients whose cancer has spread or cannot be surgically removed and who have already received standard chemotherapy plus immunotherapy.
This trial is testing a new combination of treatments—a wearable device that sends electric fields to the tumor area (tumor-treating fields) plus immunotherapy (durvalumab) and chemotherapy (gemcitabine/cisplatin)—for people with advanced bile duct or gallbladder cancer. It may be an option if you haven't had chemotherapy for advanced disease before.
This trial tests a combination of four drugs (adebrelimab, apatinib, gemcitabine, and cisplatin) as a first treatment for people with advanced or metastatic bile duct cancer that cannot be removed by surgery. The goal is to see if this combination helps shrink or control the cancer.
This study tests a new treatment combination for advanced bile duct or gallbladder cancer that has not been treated before. It aims to slow cancer growth and may be a good option if you have not had prior therapy for your cancer.
This trial is testing treatments that are customized to the specific genetic changes in your bile duct or gallbladder cancer. The goal is to find a drug that targets your tumor's unique mutation, which may help control the cancer better than a one-size-fits-all approach.
This study looks at tumor tissue samples from people with bile duct or gallbladder cancer to find biomarkers (clues in the tumor) that might help guide future treatment. By studying these samples, researchers hope to understand more about these cancers and improve care.
Hear when a new Advanced Biliary Tract Cancer(BTC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.